Milrinone or Dobutamine for Cardiogenic Shock?

September 27, 2021 00:25:40
Milrinone or Dobutamine for Cardiogenic Shock?
Critical Care Perspectives in Emergency Medicine
Milrinone or Dobutamine for Cardiogenic Shock?

Sep 27 2021 | 00:25:40

/

Show Notes

Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices.  With respect to inotropic medications, there is little data to guide optimal management and selection of agents.  In this podcast we discuss the results of a recent trial that compared milrinone with dobutamine for patients with cardiogenic shock.  Which agent was the winner?

You can get CME credit for this episode hereClick here for CME Account Creation Instructions

Other Episodes

Episode 0

December 27, 2019 00:23:35
Episode Cover

Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The...

Listen

Episode

May 17, 2025 00:26:02
Episode Cover

Palliative Care in the ED

Approximately 75% of patients older than 65 years of age are seen in an ED within 6 months of their death.  While palliative care...

Listen

Episode 0

June 20, 2017 00:24:03
Episode Cover

Pediatric and Neonatal Septic Shock

Peds EM superstars Mimi Lu and Barrie Bostick join CCPEM to review the latest clinical guidelines on hemodynamic support of pediatric and neonatal septic...

Listen